Skip to content

Dihexa

PeptidespeptideEarly stage

Availability Not yet tested in people

What it is

Dihexa is a small synthetic peptide derived from angiotensin IV and stabilised so it survives in the bloodstream. Joseph Harding's group at Washington State University built it to amplify hepatocyte growth factor signaling through its receptor, c-Met, a pathway that drives the formation of new dendritic spines and synapses.

Why people take it

The marketing claim, that dihexa is orders of magnitude more potent than BDNF at building synapses, is the most dramatic sentence in the cognitive peptide market. People reach for it hoping to rebuild something that feels lost: memory after a concussion, sharpness after a long illness, or the cognitive slope a parent's diagnosis made frightening.

How it's delivered

Oral or injectable preparations, listed on a few clinic peptide menus. There is no approved dihexa product anywhere. FDA placed dihexa acetate in the safety-risk category for compounding in September 2023, noting it had found no human exposure data by any route. The nomination was later withdrawn, and FDA plans an advisory committee review before the end of February 2027; the exact date has not been announced. Nothing about it is currently authorised.

Where the evidence stands

Entirely preclinical, and that is the whole story. The published work is rodent: angiotensin IV analogs including dihexa restoring cognition in scopolamine-impaired and aged rats and stimulating synapse formation in cultured neurons, dependent on the hepatocyte growth factor pathway. There has never been a human trial of any phase, so there is no dose, no safety profile, and no efficacy signal in people. One influential 2014 paper from the program was retracted over data integrity. Growth-factor amplification also cuts both ways: c-Met activation drives several cancers.

Estimated cost

  • No approved or lawfully compounded product, so no reference price
  • Not covered by insurance

Who offers it

We don't list providers for dihexa: there is no approved product and no lawful compounding route, so there is nothing we can point you to. Anything sold online is unregulated.

Go deeper

No cognitive peptides guide yet. The Peptide Explorer entry carries the compound record, and the peptide therapy hub explains what separates a compound with human data from one that has only ever been given to rats.

Dihexa in the Peptide Explorer · Peptide Therapy for Longevity

Longevity.io is for educational purposes only and is not medical advice. We list dihexa so the record is clear, not because a compound with zero human data belongs on a price list. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint